Position
Chief Financial Officer
Company
Maze Therapeutics
San FranciscoBiotechnologyHealth CareScience And EngineeringDescription
Maze Therapeutics, Inc. has announced the appointment of Misbah Tahir as its Chief Financial Officer, effective immediately. Misbah brings over 20 years of experience in the biopharmaceutical industry and will help drive the company's growth strategy during a pivotal time.
Quick answer
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer (September 2, 2025). Maze Therapeutics is based in San Francisco, California, United States.
- Who is the new Chief Financial Officer at Maze Therapeutics?
- Maze Therapeutics named Misbah Tahir Chief Financial Officer, announced September 2, 2025.
- What did Maze Therapeutics announce on September 2, 2025?
- Maze Therapeutics, Inc. has announced the appointment of Misbah Tahir as its Chief Financial Officer, effective immediately. Misbah brings over 20 years of experience in the biopharmaceutical industry and will help drive the company's growth strategy during a pivotal time.
- What does Maze Therapeutics do?
- Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics.
- Where is Maze Therapeutics based?
- Maze Therapeutics is based in San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Nomad Power Solutions, Inc. (September 3, 2025), Psilera (September 4, 2025), Atavistik Bio (September 15, 2025) and Northwell Health (October 1, 2025) also announced leadership changes within 45 days of Maze Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- LIXTE Biotechnology Holdings Appoints Peter Stazzone as Chief Financial Officer (September 3, 2025)
- Psilera Appoints Scott W. Rairigh as Executive Vice President of Corporate Development (September 4, 2025)
- Atavistik Bio Appoints Susan Pandya as Chief Medical Officer (September 15, 2025)
- Northwell Health Appoints John D’Angelo, MD as President and CEO (October 1, 2025)
- Wheeler Bio Appoints Jay Benson as Chief Operating Officer (October 1, 2025)
- Unlearn Appoints Kwame Marfo as Vice President of Product (July 29, 2025)
Who to call at Maze Therapeutics, and when
A new leader at Maze Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Maze Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Maze Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Maze Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Maze Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Maze Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.